Embark Laboratories
PrivateLast Round
M&A
Aug 30, 2023
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Embark Laboratories is a biotechnology company that focuses on the discovery and development of novel therapeutic targets for cardiometabolic diseases, including obesity and type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embark Laboratories Comparables
Compare Embark Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Incipiam Pharma | 79% | |
| Antag Therapeutics | 69% | |
| Equator Therapeutics | 69% |
Embark Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Aug 30, 2023 |
Key People
Founding team and executive leadership
Embark Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Seed |
| Novo Nordisk Foundation | Seed |
| Novo Holdings | Seed |
| European Research Council | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 661% MoM, from 66 to 502.
- Apr 22, 2026
Monthly visitors grew 155% MoM, reaching 1.1K.
Embark Laboratories Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Embark Laboratories's valuation, stock price, and market status.
Is Embark Laboratories a public or private company?
Embark Laboratories is a private company.
What is the current stock price of Embark Laboratories?
Embark Laboratories is a private company with no public stock price. No recent secondary market data is available.
How much is Embark Laboratories worth (valuation)?
Valuation information for Embark Laboratories is not publicly available.
Can I buy Embark Laboratories stock?
Embark Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Embark Laboratories's last funding round?
Embark Laboratories's most recent funding round was M&A on August 30, 2023.
Who are the main investors in Embark Laboratories?
Key investors in Embark Laboratories include Innovation Fund Denmark, Novo Nordisk Foundation, Novo Holdings, European Research Council.
Will Embark Laboratories IPO soon?
No public IPO plans have been announced for Embark Laboratories.
How can I track Embark Laboratories secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Embark Laboratories's secondary market activity and sign up for updates.